Paper36979840
Alzheimer's Disease from the Amyloidogenic Theory to the Puzzling Crossroads between Vascular, Metabolic and Energetic Maladaptive Plasticity.
Cerasuolo M and 3 others. Biomedicines, 2023. Cited by 15 papers, by iCite.
11 sourcespapers-2026-11-12-0.1.0
Cite this record
ConductScience Library. Alzheimer's Disease from the Amyloidogenic Theory to the Puzzling Crossroads between Vascular, Metabolic and Energetic Maladaptive Plasticity. Papers, record 36979840. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/36979840
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Alzheimer's Disease from the Amyloidogenic Theory to the Puzzling Crossroads between Vascular, Metabolic and Energetic Maladaptive Plasticity.
- PubMed
Topics0
NLM's MeSH indexing of the paper, its major topics first.
None in this release.
Grants5
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by |
|---|---|---|---|---|
| Mnesys-Piano Nazionale di Ripresa e Resilienza, 2022 | NextGenerationEU | PubMed | ||
| HORIZON-EIC-2022-PATHFINDEROPEN-01 : THOR | European commission | PubMed | ||
| FOE 2020 JRU ISBE-IT | Ministero Università e Ricerca | PubMed | ||
| FOE 2019 JRU ISBE-IT | Ministero Università e Ricerca | PubMed | ||
| PRIN 2017-2017XJ38A4_003 | Ministero Università e Ricerca | PubMed |
Source PubMed
References120
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 31,306,129 | Endothelial Mitochondrial Dysfunction in Cerebral Amyloid Angiopathy and Alzheimer's Disease. | J Alzheimers Dis | 2019 | https://conductscience.org/library/papers/31306129 | PubMed |
| 2 | 29,653,606 | NIA-AA Research Framework: Toward a biological definition of Alzheimer's disease. | Alzheimers Dement | 2018 | https://conductscience.org/library/papers/29653606 | PubMed |
| 3 | 30,668,956 | Tauopathy: A common mechanism for neurodegeneration and brain aging. | Mech Ageing Dev | 2019 | https://conductscience.org/library/papers/30668956 | PubMed |
| 4 | 32,252,068 | Medial temporal lobe connectivity and its associations with cognition in early Alzheimer's disease. | Brain | 2020 | https://conductscience.org/library/papers/32252068 | PubMed |
| 5 | 31,102,663 | The role of sleep deprivation and circadian rhythm disruption as risk factors of Alzheimer's disease. | Front Neuroendocrinol | 2019 | https://conductscience.org/library/papers/31102663 | PubMed |
| 6 | 31,601,740 | Sleep-wake cycles drive daily dynamics of synaptic phosphorylation. | Science | 2019 | https://conductscience.org/library/papers/31601740 | PubMed |
| 7 | 25,611,508 | Blood-brain barrier breakdown in the aging human hippocampus. | Neuron | 2015 | https://conductscience.org/library/papers/25611508 | PubMed |
| 8 | 31,055,573 | Human Inflammaging. | Gerontology | 2019 | https://conductscience.org/library/papers/31055573 | PubMed |
| 9 | 29,351,512 | Physiology of Astroglia. | Physiol Rev | 2018 | https://conductscience.org/library/papers/29351512 | PubMed |
| 10 | 25,355,056 | Iron transport across the blood-brain barrier: development, neurovascular regulation and cerebral amyloid angiopathy. | Cell Mol Life Sci | 2015 | https://conductscience.org/library/papers/25355056 | PubMed |
| 11 | 25,771,249 | A 2 year multidomain intervention of diet, exercise, cognitive training, and vascular risk monitoring versus control to prevent cognitive decline in at-risk elderly people (FINGER): a randomised controlled trial. | Lancet | 2015 | https://conductscience.org/library/papers/25771249 | PubMed |
| 12 | 31,964,406 | A pharmacological chaperone improves memory by reducing Aβ and tau neuropathology in a mouse model with plaques and tangles. | Mol Neurodegener | 2020 | https://conductscience.org/library/papers/31964406 | PubMed |
| 13 | 24,735,889 | Glucose hypometabolism is highly localized, but lower cortical thickness and brain atrophy are widespread in cognitively normal older adults. | Am J Physiol Endocrinol Metab | 2014 | https://conductscience.org/library/papers/24735889 | PubMed |
| 14 | 29,782,323 | Role of Blood-Brain Barrier in Alzheimer's Disease. | J Alzheimers Dis | 2018 | https://conductscience.org/library/papers/29782323 | PubMed |
| 15 | 32,376,954 | APOE4 leads to blood-brain barrier dysfunction predicting cognitive decline. | Nature | 2020 | https://conductscience.org/library/papers/32376954 | PubMed |
| 16 | 28,515,434 | Cerebral blood flow regulation and neurovascular dysfunction in Alzheimer disease. | Nat Rev Neurosci | 2017 | https://conductscience.org/library/papers/28515434 | PubMed |
| 17 | 31,221,773 | Amyloid β oligomers constrict human capillaries in Alzheimer's disease via signaling to pericytes. | Science | 2019 | https://conductscience.org/library/papers/31221773 | PubMed |
| 18 | 28,211,814 | Are Major Dementias Triggered by Poor Blood Flow to the Brain? Theoretical Considerations. | J Alzheimers Dis | 2017 | https://conductscience.org/library/papers/28211814 | PubMed |
| 19 | 30,192,999 | Deep cervical lymph node ligation aggravates AD-like pathology of APP/PS1 mice. | Brain Pathol | 2019 | https://conductscience.org/library/papers/30192999 | PubMed |
| 20 | 21,620,945 | BB14, a Nerve Growth Factor (NGF)-like peptide shown to be effective in reducing reactive astrogliosis and restoring synaptic homeostasis in a rat model of peripheral nerve injury. | Biotechnol Adv | 2012 | https://conductscience.org/library/papers/21620945 | PubMed |
Cited by12
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 15 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42,682,412 | The hippocampal subgranular zone neurogenic niche: a modular perspective on neural stem cell regulation. | Front Cell Neurosci | 2026 | https://conductscience.org/library/papers/42682412 | PubMed |
| 41,333,067 | Unraveling the complexity of cognitive impairment following high-altitude exposure: from preclinical animal models to human organoids. | Front Neurosci | 2025 | https://conductscience.org/library/papers/41333067 | PubMed |
| 40,817,910 | Cortical circuit principles predict patterns of trauma induced tauopathy in humans. | Cereb Cortex | 2025 | https://conductscience.org/library/papers/40817910 | PubMed |
| 40,724,942 | Understanding the Insulin-Degrading Enzyme: A New Look at Alzheimer's Disease and Aβ Plaque Management. | Int J Mol Sci | 2025 | https://conductscience.org/library/papers/40724942 | PubMed |
| 40,541,777 | Dietary n-3 polyunsaturated fatty acids intervention ameliorates cognitive dysfunction in db/db mice by mitigating cortical insulin resistance, mitochondrial dysfunction, and energy metabolism impairment. | J Adv Res | 2026 | https://conductscience.org/library/papers/40541777 | PubMed |
| 40,502,682 | Transcranial near infrared therapy reprograms metabolism to rescue sleep and place cell functionality. | iScience | 2025 | https://conductscience.org/library/papers/40502682 | PubMed |
| 39,995,945 | Microvascular dysfunction in a murine model of Alzheimer's disease using intravital microscopy. | Front Aging Neurosci | 2025 | https://conductscience.org/library/papers/39995945 | PubMed |
| 39,861,773 | Evolution of Alzheimer's Disease Therapeutics: From Conventional Drugs to Medicinal Plants, Immunotherapy, Microbiotherapy and Nanotherapy. | Pharmaceutics | 2025 | https://conductscience.org/library/papers/39861773 | PubMed |
| 39,595,539 | Exploring the Dynamic Changes of Brain Lipids, Lipid Rafts, and Lipid Droplets in Aging and Alzheimer's Disease. | Biomolecules | 2024 | https://conductscience.org/library/papers/39595539 | PubMed |
| 39,519,272 | From Plaques to Pathways in Alzheimer's Disease: The Mitochondrial-Neurovascular-Metabolic Hypothesis. | Int J Mol Sci | 2024 | https://conductscience.org/library/papers/39519272 | PubMed |
| 38,841,104 | P-hydroxybenzaldehyde protects Caenorhabditis elegans from oxidative stress and β-amyloid toxicity. | Front Aging Neurosci | 2024 | https://conductscience.org/library/papers/38841104 | PubMed |
| 38,487,323 | Is Alzheimer's disease an individual-centered disease? Hypotheses from the atomic levels up to mathematical models for biological systems. | Front Neurol | 2024 | https://conductscience.org/library/papers/38487323 | PubMed |
Genes23
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/36979840
GET https://conductscience.org/api/papers/v1/36979840/references?page=2